IP Library Granted Patent US 8,805,491
Granted Patent B2
US 8,805,491 · App. 10/868,395 · Granted Aug 12, 2014

Microperfusive electrical stimulation

Inventor: Gary A. Freeman (Newton Center, MA)
Assignee: ZOLL Medical Corporation
A61N1/3906
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,805,491
App. No.
10/868,395
Granted
Aug 12, 2014
Kind
B2
Abstract

A method of treating a patient in cardiac arrest (e.g., in fibrillation, electrochemical dissociation, or asystole), the method comprising delivering an agent for enhancement of cardiac function to the coronary arteries of the patient; and microperfusing the patient's cardiac tissue by electromagnetically stimulating the cardiac tissue at an energy level below a threshold sufficient to defibrillate the heart.

Claims (14)

1. A method of treating a patient in cardiac arrest (including in fibrillation, electrochemical dissociation, or asystole), the method comprising:

delivering an agent for enhancement of cardiac function to the patient's coronary arteries, wherein delivering the agent comprises intravenous infusion of the agent and a circulatory enhancement method for delivery of the agent to the coronary arteries; and

microperfusing the patient's cardiac tissue by electromagnetically stimulating the cardiac tissue with a plurality of microperfusing pulses, applied via electrodes external to the patient, wherein the microperfusing pulses are

at an energy below a threshold sufficient to defibrillate the patient's heart and below a threshold sufficient to pace the patient's heart with hemodynamic output,

but of a frequency, duration, and energy level to produce sufficient myocardial cell contraction for pumping of Calcium ions into the cell interior without causing electroporation of the myocardial cells.

2. The method of claim 1 wherein the circulatory enhancement method comprises manual chest compressions.

3. The method of claim 1 wherein the circulatory enhancement method comprises assistance by a cardiac mechanical pump.

4. The method of claim 1 further comprising delivering a defibrillation pulse to the patient's cardiac tissue following the delivering and microperfusing steps.

5. The method of claim 1 wherein the order in which the steps are performed is delivering the agent, followed by circulatory enhancement of the agent, followed by microperfusing.

6. The method of claim 1 further comprising delivering calcium.

7. The method of claim 1 wherein the electromagnetic stimulating comprises applying an electrical current.

8. The method of claim 1 wherein the electromagnetic stimulating comprises applying a magnetic field.

9. The method of claim 1 wherein the delivering step comprises cardiac compression performed by chest compression.

10. The method of claim 1 , wherein the metabolic agent comprises a metabolite selected from the group consisting of aspartate, oxidized form of nicotinamide adenine dinucleotide (NAD+), proglycogen, and 2-oxoglutarate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2004
From: FREEMAN, GARY A.
To: ZOLL MEDICAL CORPORATION
Reel/Frame 015263/0436 →
Continuity (2)
Provisional Application 60564160 · Apr 20, 2004
Related Publication 20050234515A1 · Oct 20, 2005